News
Symposium titled “Gliptins and SGLT-2 Inhibitors: A Pharmacological and Clinical Appraisal”
Feb 4, 2026
The Department of Pharmacology, Father Muller Medical College, successfully organized a Symposium titled “Gliptins and SGLT-2 Inhibitors: A Pharmacological and Clinical Appraisal” on 30th January 2026, from 2.45 PM onwards, at the Muller Mini Hall, Father Muller Convention Centre. The symposium was conceptualized with the objective of providing an updated and integrated understanding of the pharmacological mechanisms and clinical applications of gliptins and SGLT-2 inhibitors, which play a pivotal role in the management of diabetes mellitus and associated comorbidities.
The program commenced with a welcome address by Dr Chandralekha N, Professor and Head, Department of Pharmacology, who warmly welcomed the dignitaries, resource persons, moderators, and participants. Rev Fr Micheal Santhumayor, Administrator, Father Muller Medical College, addressed the gathering and emphasized the academic relevance of the symposium and the growing clinical importance of gliptins and SGLT-2 inhibitors in contemporary practice. The moderators for the scientific sessions were formally introduced by Dr Scandashree K, Associate Professor, Department of Pharmacology, who highlighted their academic credentials and interdisciplinary expertise. The proceedings of the symposium were efficiently coordinated by Dr Pooja M, who served as the Master of Ceremonies and ensured the smooth conduct of the academic sessions and transitions.
The academic program comprised three focused scientific sessions. The first session on “Pharmacological Insights into Gliptins and SGLT-2 Inhibitors” was delivered by Dr Padmaja Udaykumar, Professor, Department of Pharmacology. The session provided a comprehensive overview of mechanisms of action, pharmacokinetics, and safety profiles of these drug classes.
The second session on “Current Therapeutic Status of Gliptins” was presented by Dr Sudeep K, Professor, Department of Endocrinology, who highlighted evidence-based clinical use, guideline recommendations, and practical considerations in patient management.
The third session, “SGLT-2 Inhibitors in Real-World Practice”, was delivered by Dr Jostol Pinto, Professor, Department of Cardiology, focusing on cardiovascular and renal benefits, real-world data, and emerging indications beyond glycemic control.
All three sessions were moderated by Dr Smitha Bhat, Professor and Head, Department of Medicine and Dr Manjunath Kulkarni, Professor and Head, Department of Nephrology.
The symposium witnessed active participation from 120 delegates, including faculty members, postgraduate students, and clinicians from various medical colleges, reflecting the academic relevance and interdisciplinary appeal of the topic. The last session was followed by interactive discussions, during which participants engaged with the speakers on clinical dilemmas, and practical challenges prescribing DPP4 inhibitors and SGLT 2 inhibitors.
Feedback from participants indicated that the symposium was highly informative, clinically relevant, and academically enriching, meeting its stated objectives
The event was coordinated by Dr Chandralekha N, Professor and Head, Department of Pharmacology, as Organizing Chairperson and Dr Scandashree K, Associate Professor, Department of Pharmacology, as Organizing Secretary, with guidance and support from Rev Fr Micheal Santhumayor, Administrator, Father Muller Medical College and Dr Antony Sylvan D’Souza, Dean, Father Muller Medical College.
The Department of Pharmacology extends its sincere gratitude to all resource persons, moderators, participants, and the institutional administration for their valuable contributions toward the success of the symposium.
